Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicetile in mild to moderate carpal tunnel syndrome
2014-002289-62Phase 4Completed
- Sponsor
- Leadiant Biosciences
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetyl-l-carnitine in carpal tunnel syndrome (CTS), sponsored by Leadiant Biosciences. Primary endpoint: Improvement in sensory nerve conduction velocity of the median nerve. Started Jul 2014; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on 2014-002289-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002289-62.